Science in Real Time (ScienceIRT) Transistor (https://transistor.fm) https://feeds.transistor.fm/scienceirt Science in Real Time (ScienceIRT) podcast serves as a digital lab notebook—an open-access, conversational platform that brings the stories behind cutting-edge life science tools and techniques into focus. From biologics to predictive analytics and AI-powered innovation, our guests are shaping the future of therapeutic discovery in real time. 2025 Araceli Biosciences 91315ca7-4329-5bd8-be61-0eb791c4a929 yes Opening the Lab Notebook en Wed, 13 May 2026 07:51:15 -0500 Wed, 13 May 2026 07:52:09 -0500 https://www.aracelibio.com/science-irt-podcast-biology-big-data/ https://img.transistorcdn.com/5ciWeakG4zQkxQ-ZDQ0rvBxH8k-op6JNxwpJDB4275U/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mM2E5/MjY3ZDA3N2YzNjIy/YTM4ZDYwODllYWM2/OGM0Yi5wbmc.jpg Science in Real Time (ScienceIRT) https://www.aracelibio.com/science-irt-podcast-biology-big-data/ episodic Araceli Biosciences Science in Real Time (ScienceIRT) podcast serves as a digital lab notebook—an open-access, conversational platform that brings the stories behind cutting-edge life science tools and techniques into focus. From biologics to predictive analytics and AI-powered innovation, our guests are shaping the future of therapeutic discovery in real time. Science in Real Time (ScienceIRT) podcast serves as a digital lab notebook—an open-access, conversational platform that brings the stories behind cutting-edge life science tools and techniques into focus. Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI Carli Reyes creyes@aracelibio.com No No Spotlight: Imaging the Future — High-Content Screening, AI, and the Next Era of Phenotypic Discovery with Timothy P. Spicer, PhD 2 2 11 11 Spotlight: Imaging the Future — High-Content Screening, AI, and the Next Era of Phenotypic Discovery with Timothy P. Spicer, PhD full b543ad2c-5165-48b6-9bd0-05f91630113e https://share.transistor.fm/s/97f49a91 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Timothy P. Spicer, Director of Assay Development & Screening at the The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, to explore how high-content screening, phenotypic discovery, and advanced imaging are reshaping modern drug discovery. Drawing on decades of experience at the forefront of translational science, Dr. Spicer shares how the field has evolved beyond traditional screening toward data-rich, image-driven approaches that unlock deeper biological understanding.

What You’ll Hear:

  • From Screening to Systems-Level Insight – Dr. Spicer’s journey through the evolution of assay development and how high-content approaches have transformed discovery.
  • Defining High-Content Today – what “high-content screening” really means now—and how it’s changed over the last decade.
  • Phenotypes as Decision Drivers – why phenotypic screening is resurging and how imaging enables teams to embrace biological complexity.
  • AI, Automation & Reality vs Hype – where machine learning is truly impactful in imaging workflows—and where expectations still outpace reality.
  • Collaboration as a Catalyst – how partnerships between academia, biotech, and technology platforms accelerate innovation.
  • The Next Inflection Point – Dr. Spicer’s perspective on what the next 5–10 years of high-content screening will unlock.

🌐 Explore & Connect
Learn more about Dr. Tim Spicer’s work at UF Scripps and how advances in high-content screening and imaging are accelerating phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Timothy P. Spicer, Director of Assay Development & Screening at the The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, to explore how high-content screening, phenotypic discovery, and advanced imaging are reshaping modern drug discovery. Drawing on decades of experience at the forefront of translational science, Dr. Spicer shares how the field has evolved beyond traditional screening toward data-rich, image-driven approaches that unlock deeper biological understanding.

What You’ll Hear:

  • From Screening to Systems-Level Insight – Dr. Spicer’s journey through the evolution of assay development and how high-content approaches have transformed discovery.
  • Defining High-Content Today – what “high-content screening” really means now—and how it’s changed over the last decade.
  • Phenotypes as Decision Drivers – why phenotypic screening is resurging and how imaging enables teams to embrace biological complexity.
  • AI, Automation & Reality vs Hype – where machine learning is truly impactful in imaging workflows—and where expectations still outpace reality.
  • Collaboration as a Catalyst – how partnerships between academia, biotech, and technology platforms accelerate innovation.
  • The Next Inflection Point – Dr. Spicer’s perspective on what the next 5–10 years of high-content screening will unlock.

🌐 Explore & Connect
Learn more about Dr. Tim Spicer’s work at UF Scripps and how advances in high-content screening and imaging are accelerating phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Thu, 30 Apr 2026 11:30:00 -0500 Araceli Biosciences Araceli Biosciences 1255 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Timothy P. Spicer, Director of Assay Development & Screening at the The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, to explore how high-content screening, phenotypic discovery, and advanced imaging are reshaping modern drug discovery. Drawing on decades of experience at the forefront of translational science, Dr. Spicer shares how the field has evolved beyond traditional screening toward data-rich, image-driven approaches that unlock deeper biological understanding.

What You’ll Hear:

  • From Screening to Systems-Level Insight – Dr. Spicer’s journey through the evolution of assay development and how high-content approaches have transformed discovery.
  • Defining High-Content Today – what “high-content screening” really means now—and how it’s changed over the last decade.
  • Phenotypes as Decision Drivers – why phenotypic screening is resurging and how imaging enables teams to embrace biological complexity.
  • AI, Automation & Reality vs Hype – where machine learning is truly impactful in imaging workflows—and where expectations still outpace reality.
  • Collaboration as a Catalyst – how partnerships between academia, biotech, and technology platforms accelerate innovation.
  • The Next Inflection Point – Dr. Spicer’s perspective on what the next 5–10 years of high-content screening will unlock.

🌐 Explore & Connect
Learn more about Dr. Tim Spicer’s work at UF Scripps and how advances in high-content screening and imaging are accelerating phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI No Spotlight: High-Content Discovery and the Future of Phenotypic Screening with Claudia McCown, PhD (UF Scripps) 2 2 10 10 Spotlight: High-Content Discovery and the Future of Phenotypic Screening with Claudia McCown, PhD (UF Scripps) full 91d64751-7ae0-482a-bc2a-45e6932e04a7 https://share.transistor.fm/s/64bbe7d1 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Claudia McCown, a leader in high-content screening and phenotypic discovery, to explore how imaging, automation, and AI are transforming modern drug discovery. Drawing on her work at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Dr. McCown shares how the field is evolving from traditional high-throughput screening to data-rich, image-based approaches that reveal deeper biological insight.

What You’ll Hear:

  • From Throughput to Insight – Dr. McCown’s journey from classical screening approaches to high-content, image-based discovery.
  • Phenotypes at Scale – how high-content screening captures complex cellular behaviors that traditional assays miss.
  • AI Meets Imaging – the role of automation and machine learning in accelerating and refining biological analysis.
  • Collaboration Across Disciplines – lessons from bridging academia, biotech, and technology platforms like Araceli’s Endeavor.
  • The Future of Discovery – how integrated workflows will reshape drug discovery and empower the next generation of scientists.


🌐 Explore & Connect
Learn more about Dr. Claudia McCown’s work in high-content screening at UF Scripps and how collaborations with Araceli Biosciences are advancing phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Claudia McCown, a leader in high-content screening and phenotypic discovery, to explore how imaging, automation, and AI are transforming modern drug discovery. Drawing on her work at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Dr. McCown shares how the field is evolving from traditional high-throughput screening to data-rich, image-based approaches that reveal deeper biological insight.

What You’ll Hear:

  • From Throughput to Insight – Dr. McCown’s journey from classical screening approaches to high-content, image-based discovery.
  • Phenotypes at Scale – how high-content screening captures complex cellular behaviors that traditional assays miss.
  • AI Meets Imaging – the role of automation and machine learning in accelerating and refining biological analysis.
  • Collaboration Across Disciplines – lessons from bridging academia, biotech, and technology platforms like Araceli’s Endeavor.
  • The Future of Discovery – how integrated workflows will reshape drug discovery and empower the next generation of scientists.


🌐 Explore & Connect
Learn more about Dr. Claudia McCown’s work in high-content screening at UF Scripps and how collaborations with Araceli Biosciences are advancing phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Wed, 01 Apr 2026 21:09:30 -0500 Araceli Biosciences Araceli Biosciences 1273 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Claudia McCown, a leader in high-content screening and phenotypic discovery, to explore how imaging, automation, and AI are transforming modern drug discovery. Drawing on her work at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Dr. McCown shares how the field is evolving from traditional high-throughput screening to data-rich, image-based approaches that reveal deeper biological insight.

What You’ll Hear:

  • From Throughput to Insight – Dr. McCown’s journey from classical screening approaches to high-content, image-based discovery.
  • Phenotypes at Scale – how high-content screening captures complex cellular behaviors that traditional assays miss.
  • AI Meets Imaging – the role of automation and machine learning in accelerating and refining biological analysis.
  • Collaboration Across Disciplines – lessons from bridging academia, biotech, and technology platforms like Araceli’s Endeavor.
  • The Future of Discovery – how integrated workflows will reshape drug discovery and empower the next generation of scientists.


🌐 Explore & Connect
Learn more about Dr. Claudia McCown’s work in high-content screening at UF Scripps and how collaborations with Araceli Biosciences are advancing phenotypic discovery.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague interested in the future of imaging, AI, and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI No Spotlight: Can AI See What Scientists Can’t? How Machine Learning Is Unlocking Hidden Phenotypes in Cell Imaging with Reese Findley, PhD (ViQi) 2 2 9 9 Spotlight: Can AI See What Scientists Can’t? How Machine Learning Is Unlocking Hidden Phenotypes in Cell Imaging with Reese Findley, PhD (ViQi) full b31905c0-e2d6-4de7-86f9-8820c7c3a4c2 https://share.transistor.fm/s/079b0542 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Reese Findley, Senior Scientists at ViQi, to explore how machine learning is transforming the way we interpret complex biological systems. Drawing on her background in neuroscience and behavioral research, Dr. Findley shares how her work uncovering hidden behavioral states in animal models evolved into designing AI frameworks that detect subtle, high-dimensional cellular phenotypes in imaging data. 

What You’ll Hear:

  • From Brains to Biology – Dr. Findley’s journey from neuroscience and behavior research into AI-driven cell imaging.
  • Hidden Phenotypes Revealed – how machine learning models uncover patterns in cellular data that traditional analysis may miss.
  • Making AI Interpretable – why transparency and collaboration are essential for building trust between computational and experimental teams.
  • Women in AI & Science – mentorship, resilience, and navigating interdisciplinary career paths.
  • The Future of AI in Discovery – opportunities, ethical responsibilities, and how emerging scientists can prepare for a data-driven era of biology.


🌐 Explore & Connect
Learn more about Dr. Reese Findley and her work at ViQi, and explore how AI-powered imaging is accelerating biological insight.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s curious about how AI is reshaping cell biology and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Reese Findley, Senior Scientists at ViQi, to explore how machine learning is transforming the way we interpret complex biological systems. Drawing on her background in neuroscience and behavioral research, Dr. Findley shares how her work uncovering hidden behavioral states in animal models evolved into designing AI frameworks that detect subtle, high-dimensional cellular phenotypes in imaging data. 

What You’ll Hear:

  • From Brains to Biology – Dr. Findley’s journey from neuroscience and behavior research into AI-driven cell imaging.
  • Hidden Phenotypes Revealed – how machine learning models uncover patterns in cellular data that traditional analysis may miss.
  • Making AI Interpretable – why transparency and collaboration are essential for building trust between computational and experimental teams.
  • Women in AI & Science – mentorship, resilience, and navigating interdisciplinary career paths.
  • The Future of AI in Discovery – opportunities, ethical responsibilities, and how emerging scientists can prepare for a data-driven era of biology.


🌐 Explore & Connect
Learn more about Dr. Reese Findley and her work at ViQi, and explore how AI-powered imaging is accelerating biological insight.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s curious about how AI is reshaping cell biology and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Fri, 13 Feb 2026 09:21:24 -0600 Araceli Biosciences Araceli Biosciences 1171 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Reese Findley, Senior Scientists at ViQi, to explore how machine learning is transforming the way we interpret complex biological systems. Drawing on her background in neuroscience and behavioral research, Dr. Findley shares how her work uncovering hidden behavioral states in animal models evolved into designing AI frameworks that detect subtle, high-dimensional cellular phenotypes in imaging data. 

What You’ll Hear:

  • From Brains to Biology – Dr. Findley’s journey from neuroscience and behavior research into AI-driven cell imaging.
  • Hidden Phenotypes Revealed – how machine learning models uncover patterns in cellular data that traditional analysis may miss.
  • Making AI Interpretable – why transparency and collaboration are essential for building trust between computational and experimental teams.
  • Women in AI & Science – mentorship, resilience, and navigating interdisciplinary career paths.
  • The Future of AI in Discovery – opportunities, ethical responsibilities, and how emerging scientists can prepare for a data-driven era of biology.


🌐 Explore & Connect
Learn more about Dr. Reese Findley and her work at ViQi, and explore how AI-powered imaging is accelerating biological insight.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us on the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s curious about how AI is reshaping cell biology and drug discovery.

🔗 Links


Copyright Music by: Scientific "How it Goes"

]]> Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI No Spotlight: Reimagining Discovery — Leadership Lessons for a New Era of Biotech with Kirk Malloy, PhD 2 2 8 8 Spotlight: Reimagining Discovery — Leadership Lessons for a New Era of Biotech with Kirk Malloy, PhD full 72f4b3ad-5679-44dd-a1ce-a1f18c4cd147 https://share.transistor.fm/s/2e2cc18c In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Kirk Malloy, Founder and Principal of BioAdvisors, LLC, to unpack what it truly takes to build, scale, and lead life science companies through periods of rapid innovation. Drawing on decades of leadership experience at companies like Illumina, Biosite, QIAGEN, and Verogen, Dr. Malloy shares hard-earned lessons on aligning scientific vision with strategic execution — and why leadership mindset matters more than ever in today’s data-driven discovery landscape.


What You’ll Hear:

  • A Leadership Journey Across Biotech – Dr. Malloy’s path through some of the most transformative companies in life sciences.
  • Scaling with Intention – the strategic decisions that enable sustainable growth without losing scientific focus.
  • Aligning Vision and Strategy – how leaders can bridge R&D, commercial teams, and long-term company direction.
  • The Future of Discovery Workflows – where AI, imaging, and automation are creating real differentiation.
  • Leadership for the Next Era – advice for emerging leaders navigating complexity in modern biotech.

🌐 Explore & Connect
Learn more about Dr. Kirk Malloy and his work at BioAdvisors, LLC, and explore how leadership and strategy continue to shape innovation across the life sciences.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s thinking about the future of discovery, leadership, and innovation in biotech!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Kirk Malloy, Founder and Principal of BioAdvisors, LLC, to unpack what it truly takes to build, scale, and lead life science companies through periods of rapid innovation. Drawing on decades of leadership experience at companies like Illumina, Biosite, QIAGEN, and Verogen, Dr. Malloy shares hard-earned lessons on aligning scientific vision with strategic execution — and why leadership mindset matters more than ever in today’s data-driven discovery landscape.


What You’ll Hear:

  • A Leadership Journey Across Biotech – Dr. Malloy’s path through some of the most transformative companies in life sciences.
  • Scaling with Intention – the strategic decisions that enable sustainable growth without losing scientific focus.
  • Aligning Vision and Strategy – how leaders can bridge R&D, commercial teams, and long-term company direction.
  • The Future of Discovery Workflows – where AI, imaging, and automation are creating real differentiation.
  • Leadership for the Next Era – advice for emerging leaders navigating complexity in modern biotech.

🌐 Explore & Connect
Learn more about Dr. Kirk Malloy and his work at BioAdvisors, LLC, and explore how leadership and strategy continue to shape innovation across the life sciences.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s thinking about the future of discovery, leadership, and innovation in biotech!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> Tue, 27 Jan 2026 15:26:33 -0600 Araceli Biosciences Araceli Biosciences 1363 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Kirk Malloy, Founder and Principal of BioAdvisors, LLC, to unpack what it truly takes to build, scale, and lead life science companies through periods of rapid innovation. Drawing on decades of leadership experience at companies like Illumina, Biosite, QIAGEN, and Verogen, Dr. Malloy shares hard-earned lessons on aligning scientific vision with strategic execution — and why leadership mindset matters more than ever in today’s data-driven discovery landscape.


What You’ll Hear:

  • A Leadership Journey Across Biotech – Dr. Malloy’s path through some of the most transformative companies in life sciences.
  • Scaling with Intention – the strategic decisions that enable sustainable growth without losing scientific focus.
  • Aligning Vision and Strategy – how leaders can bridge R&D, commercial teams, and long-term company direction.
  • The Future of Discovery Workflows – where AI, imaging, and automation are creating real differentiation.
  • Leadership for the Next Era – advice for emerging leaders navigating complexity in modern biotech.

🌐 Explore & Connect
Learn more about Dr. Kirk Malloy and his work at BioAdvisors, LLC, and explore how leadership and strategy continue to shape innovation across the life sciences.

Have an idea for a topic or guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at the ScienceIRT website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave a review, and share it with a colleague who’s thinking about the future of discovery, leadership, and innovation in biotech!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI No Special: Inside SBI2 2025 — How AI, Imaging, and Multi-Omics Are Transforming Discovery 1 1 7 7 Special: Inside SBI2 2025 — How AI, Imaging, and Multi-Omics Are Transforming Discovery full d72a2bc1-932d-4db8-9c1a-43c9173ce693 https://share.transistor.fm/s/3b79c42e In this episode of Science in Real Time, host Carli Reyes brings listeners a behind-the-scenes recap of SBI2 2025, the premier conference for quantitative imaging, high-content screening, and bioinformatics. Carli breaks down the biggest scientific trends shaping the future of imaging—from foundation models and AI-driven analysis to multi-omics integration and next-generation 3D model systems.

This fast-paced, insight-rich episode dives into the keynotes, workshops, posters, and technology showcases that defined the meeting, while highlighting standout contributions from the Araceli Biosciences team. If you work in phenotypic screening, cell imaging, computational biology, or drug discovery, this recap distills what you need to know!

🎧 What You’ll Hear:

  • Why SBI2 matters for the future of quantitative imaging 
  • Top trends in Bioimaging: deep learning, reproducibility & cloud pipelines 
  • Araceli Biosciences highlights at SBI2, including:

Victoria Arinella (UF Scripps) — improving assay reproducibility through automated image quality metrics.
Dr. Claudia McCown (UF Scripps) — advancing collaborative imaging and multi-site data workflows.
Conference reflections from Dr. Kristin Halfpenny, emphasizing the convergence of AI, 3D biology, imaging automation, and analytics.

  • Multi-omics + imaging = The next big leap
  • What makes SBI2 a unique scientific community
  • What’s next in imaging: AI integration, 3D models & automation

🌐 Explore & Connect:
Learn more about SBI2, ScienceIRT and Araceli Biosciences at: 

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links: 

Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes brings listeners a behind-the-scenes recap of SBI2 2025, the premier conference for quantitative imaging, high-content screening, and bioinformatics. Carli breaks down the biggest scientific trends shaping the future of imaging—from foundation models and AI-driven analysis to multi-omics integration and next-generation 3D model systems.

This fast-paced, insight-rich episode dives into the keynotes, workshops, posters, and technology showcases that defined the meeting, while highlighting standout contributions from the Araceli Biosciences team. If you work in phenotypic screening, cell imaging, computational biology, or drug discovery, this recap distills what you need to know!

🎧 What You’ll Hear:

  • Why SBI2 matters for the future of quantitative imaging 
  • Top trends in Bioimaging: deep learning, reproducibility & cloud pipelines 
  • Araceli Biosciences highlights at SBI2, including:

Victoria Arinella (UF Scripps) — improving assay reproducibility through automated image quality metrics.
Dr. Claudia McCown (UF Scripps) — advancing collaborative imaging and multi-site data workflows.
Conference reflections from Dr. Kristin Halfpenny, emphasizing the convergence of AI, 3D biology, imaging automation, and analytics.

  • Multi-omics + imaging = The next big leap
  • What makes SBI2 a unique scientific community
  • What’s next in imaging: AI integration, 3D models & automation

🌐 Explore & Connect:
Learn more about SBI2, ScienceIRT and Araceli Biosciences at: 

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links: 

Copyright Music by: Scientific "How it Goes"

]]> Mon, 17 Nov 2025 13:00:35 -0600 Araceli Biosciences Araceli Biosciences 427 In this episode of Science in Real Time, host Carli Reyes brings listeners a behind-the-scenes recap of SBI2 2025, the premier conference for quantitative imaging, high-content screening, and bioinformatics. Carli breaks down the biggest scientific trends shaping the future of imaging—from foundation models and AI-driven analysis to multi-omics integration and next-generation 3D model systems.

This fast-paced, insight-rich episode dives into the keynotes, workshops, posters, and technology showcases that defined the meeting, while highlighting standout contributions from the Araceli Biosciences team. If you work in phenotypic screening, cell imaging, computational biology, or drug discovery, this recap distills what you need to know!

🎧 What You’ll Hear:

  • Why SBI2 matters for the future of quantitative imaging 
  • Top trends in Bioimaging: deep learning, reproducibility & cloud pipelines 
  • Araceli Biosciences highlights at SBI2, including:

Victoria Arinella (UF Scripps) — improving assay reproducibility through automated image quality metrics.
Dr. Claudia McCown (UF Scripps) — advancing collaborative imaging and multi-site data workflows.
Conference reflections from Dr. Kristin Halfpenny, emphasizing the convergence of AI, 3D biology, imaging automation, and analytics.

  • Multi-omics + imaging = The next big leap
  • What makes SBI2 a unique scientific community
  • What’s next in imaging: AI integration, 3D models & automation

🌐 Explore & Connect:
Learn more about SBI2, ScienceIRT and Araceli Biosciences at: 

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links: 

Copyright Music by: Scientific "How it Goes"

]]> SBI2 2025 conference, SBI2 recap, quantitative imaging, high-content imaging, high-content screening, AI in microscopy, AI for bioimaging, AI in drug discovery, biological image analysis, phenotypic screening, phenotypic drug discovery, Cell Painting assay, Cell Painting phenotyping, multi-omics integration, multi-omics imaging, imaging informatics, bioimaging informatics, microscopy informatics, 3D cell models, organoid imaging, 3D screening platforms, imaging data analysis, automated image analysis, imaging reproducibility, image quality metrics, cloud-based imaging analysis, cloud bioimaging pipelines, deep-learning segmentation, high-throughput imaging, image-based drug discovery, imaging assay development, imaging data pipelines, foundation models biology, AI scientists, integrated imaging workflows, imaging and genomics integration, imaging and proteomics integration, collaborative imaging workflows, improving reproducibility in bioimaging, future of quantitative imaging, trends in imaging informatics, Araceli Biosciences, Araceli Bio imaging, Science in Real Time podcast, ScienceIRT podcast, bioimaging conference highlights No Spotlight: How Semarion Is Revolutionizing Cell Handling with CTO & Co-Founder Tarun Vemulkar, PhD 1 1 6 6 Spotlight: How Semarion Is Revolutionizing Cell Handling with CTO & Co-Founder Tarun Vemulkar, PhD full 383335b6-bae6-4a1e-a9c1-cb797082bc4b https://share.transistor.fm/s/01bd707b In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Tarun Vemulkar, CTO and Co-Founder of Semarion, to explore how their groundbreaking SemaCyte® platform is reshaping the way scientists handle, study, and analyze cells. They dive into the intersection of materials science and cell biology, unpacking how Semarion’s smart materials enable faster, more reproducible cell-based assays — ultimately accelerating the path from discovery to therapy.

What You’ll Hear:

  • The Origins of Semarion – how the team spun out to solve long-standing challenges in cell handling.
  • The SemaCyte® Platform Explained – how controllable microcarriers enable miniaturized, high-precision cell assays.
  • Bridging Materials Science and Biology – how Semarion’s interdisciplinary approach is unlocking new efficiencies in drug discovery workflows.
  • Real-World Applications – use cases for pharma, biotech, and academia in streamlining screening and model validation.
  • Looking Ahead – where Semarion sees the future of smart materials and how they’re scaling their impact across the life sciences ecosystem.

🌐 Explore & Connect

Learn more about Semarion and the SemaCyte® platform on their website or LinkedIn. 


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Tarun Vemulkar, CTO and Co-Founder of Semarion, to explore how their groundbreaking SemaCyte® platform is reshaping the way scientists handle, study, and analyze cells. They dive into the intersection of materials science and cell biology, unpacking how Semarion’s smart materials enable faster, more reproducible cell-based assays — ultimately accelerating the path from discovery to therapy.

What You’ll Hear:

  • The Origins of Semarion – how the team spun out to solve long-standing challenges in cell handling.
  • The SemaCyte® Platform Explained – how controllable microcarriers enable miniaturized, high-precision cell assays.
  • Bridging Materials Science and Biology – how Semarion’s interdisciplinary approach is unlocking new efficiencies in drug discovery workflows.
  • Real-World Applications – use cases for pharma, biotech, and academia in streamlining screening and model validation.
  • Looking Ahead – where Semarion sees the future of smart materials and how they’re scaling their impact across the life sciences ecosystem.

🌐 Explore & Connect

Learn more about Semarion and the SemaCyte® platform on their website or LinkedIn. 


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> Mon, 20 Oct 2025 08:20:28 -0500 Araceli Biosciences Araceli Biosciences 1537 In this episode of Science in Real Time, host Carli Reyes sits down with Dr. Tarun Vemulkar, CTO and Co-Founder of Semarion, to explore how their groundbreaking SemaCyte® platform is reshaping the way scientists handle, study, and analyze cells. They dive into the intersection of materials science and cell biology, unpacking how Semarion’s smart materials enable faster, more reproducible cell-based assays — ultimately accelerating the path from discovery to therapy.

What You’ll Hear:

  • The Origins of Semarion – how the team spun out to solve long-standing challenges in cell handling.
  • The SemaCyte® Platform Explained – how controllable microcarriers enable miniaturized, high-precision cell assays.
  • Bridging Materials Science and Biology – how Semarion’s interdisciplinary approach is unlocking new efficiencies in drug discovery workflows.
  • Real-World Applications – use cases for pharma, biotech, and academia in streamlining screening and model validation.
  • Looking Ahead – where Semarion sees the future of smart materials and how they’re scaling their impact across the life sciences ecosystem.

🌐 Explore & Connect

Learn more about Semarion and the SemaCyte® platform on their website or LinkedIn. 


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Links

Copyright Music by: Scientific "How it Goes"

]]> Science, Science in Real Time, ScienceIRT, Araceli Biosciences, Breakthroughs, Drug Discovery, AI No Molecule Talk: CellCLIP: When Cell Painting Meets AI and Natural Language 1 1 5 5 Molecule Talk: CellCLIP: When Cell Painting Meets AI and Natural Language full 1e3ff645-9f45-4ff4-9773-d7d8891c6c57 https://share.transistor.fm/s/37e92110 In this Molecule Talk episode, host Carli Reyes explores CellCLIP, a provocative new approach at the intersection of high-content imaging and AI. Based on a June 2025 preprint, CellCLIP attempts to link Cell Painting images with natural language descriptions of perturbations, making cellular data more interpretable, searchable, and useful across disciplines. While still preliminary and not yet peer-reviewed, the idea has the potential to transform how scientists connect cell morphology with biological concepts.

What You’ll Hear:

  • Cell Painting 101 — how high-content imaging creates “morphological fingerprints” of cells, and why these fingerprints are powerful but hard to interpret.
  • The CellCLIP idea — adapting the CLIP model from computer vision to align cell images with text descriptions like drug names, pathways, or gene knockouts.
  • Proof-of-concept results — retrieval tests, mechanism-of-action classification, and generalization across genetic and chemical perturbations.
  • Why it matters — from improving interpretability to enabling cross-modal integration of biology, and even accelerating drug discovery.
  • Open questions — how well CellCLIP handles unseen drugs, whether it learns biology vs. memorization, and how it will scale to massive datasets like JUMP-Cell Painting.

Together, these insights highlight a shift toward bridging cell biology and natural language — creating tools that could help scientists move from abstract image features to intuitive, actionable biological concepts.

Got an idea for a topic or guest you’d love to hear on Molecule Talk? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:


Copyright Music by: Scientific "How it Goes"

]]> In this Molecule Talk episode, host Carli Reyes explores CellCLIP, a provocative new approach at the intersection of high-content imaging and AI. Based on a June 2025 preprint, CellCLIP attempts to link Cell Painting images with natural language descriptions of perturbations, making cellular data more interpretable, searchable, and useful across disciplines. While still preliminary and not yet peer-reviewed, the idea has the potential to transform how scientists connect cell morphology with biological concepts.

What You’ll Hear:

  • Cell Painting 101 — how high-content imaging creates “morphological fingerprints” of cells, and why these fingerprints are powerful but hard to interpret.
  • The CellCLIP idea — adapting the CLIP model from computer vision to align cell images with text descriptions like drug names, pathways, or gene knockouts.
  • Proof-of-concept results — retrieval tests, mechanism-of-action classification, and generalization across genetic and chemical perturbations.
  • Why it matters — from improving interpretability to enabling cross-modal integration of biology, and even accelerating drug discovery.
  • Open questions — how well CellCLIP handles unseen drugs, whether it learns biology vs. memorization, and how it will scale to massive datasets like JUMP-Cell Painting.

Together, these insights highlight a shift toward bridging cell biology and natural language — creating tools that could help scientists move from abstract image features to intuitive, actionable biological concepts.

Got an idea for a topic or guest you’d love to hear on Molecule Talk? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:


Copyright Music by: Scientific "How it Goes"

]]> Thu, 25 Sep 2025 04:00:00 -0500 Araceli Biosciences Araceli Biosciences 494 In this Molecule Talk episode, host Carli Reyes explores CellCLIP, a provocative new approach at the intersection of high-content imaging and AI. Based on a June 2025 preprint, CellCLIP attempts to link Cell Painting images with natural language descriptions of perturbations, making cellular data more interpretable, searchable, and useful across disciplines. While still preliminary and not yet peer-reviewed, the idea has the potential to transform how scientists connect cell morphology with biological concepts.

What You’ll Hear:

  • Cell Painting 101 — how high-content imaging creates “morphological fingerprints” of cells, and why these fingerprints are powerful but hard to interpret.
  • The CellCLIP idea — adapting the CLIP model from computer vision to align cell images with text descriptions like drug names, pathways, or gene knockouts.
  • Proof-of-concept results — retrieval tests, mechanism-of-action classification, and generalization across genetic and chemical perturbations.
  • Why it matters — from improving interpretability to enabling cross-modal integration of biology, and even accelerating drug discovery.
  • Open questions — how well CellCLIP handles unseen drugs, whether it learns biology vs. memorization, and how it will scale to massive datasets like JUMP-Cell Painting.

Together, these insights highlight a shift toward bridging cell biology and natural language — creating tools that could help scientists move from abstract image features to intuitive, actionable biological concepts.

Got an idea for a topic or guest you’d love to hear on Molecule Talk? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:


Copyright Music by: Scientific "How it Goes"

]]> Science in Real Time podcast, BioScope podcast, Araceli Biosciences, organoids research, kidney organoids, mini-brains neuroscience, microglia brain development, CellForge AI, predictive biology, stem cell research, drug discovery innovation, precision medicine, disease modeling, prenatal health research, biotech innovation, future of medicine, biomedical science, AI in biology, AI in healthcare, healthcare innovation, medical breakthroughs, synthetic biology, regenerative medicine, digital biology, CellCLIP, life science research, biotech community, translational research, medical research advancements No Funding Focus: Pharma Bets, AI Raises, and Policy Shifts 1 1 4 4 Funding Focus: Pharma Bets, AI Raises, and Policy Shifts full f7f610c2-172d-434b-a908-4487d8825d78 https://share.transistor.fm/s/3b19c184 In this month’s Funding Focus, host Carli Reyes unpacks the deals, policies, and investments shaping the future of biotech and drug discovery. From billion-dollar pharma bets to government-backed strategies, we explore how capital is accelerating science on a global scale.

What you'll hear:

  • Novo Nordisk’s $550M partnership with Replicate Bioscience to advance self-replicating RNA therapies.
  • The UK’s £1.12B industrial strategy to position Britain as Europe’s biotech hub by 2030.
  • Phenomic AI’s $20M Series A, fueling the convergence of imaging and AI in oncology drug discovery.
  • The bigger picture: how public and private funding are converging into a global biotech ecosystem.

We'll also share behind-the-scenes context and a look ahead at September — from the next wave of AI-biotech partnerships to new government R&D packages that could reshape where startups take root.

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


🔗 References:

Copyright Music by: Scientific "How it Goes"

]]> In this month’s Funding Focus, host Carli Reyes unpacks the deals, policies, and investments shaping the future of biotech and drug discovery. From billion-dollar pharma bets to government-backed strategies, we explore how capital is accelerating science on a global scale.

What you'll hear:

  • Novo Nordisk’s $550M partnership with Replicate Bioscience to advance self-replicating RNA therapies.
  • The UK’s £1.12B industrial strategy to position Britain as Europe’s biotech hub by 2030.
  • Phenomic AI’s $20M Series A, fueling the convergence of imaging and AI in oncology drug discovery.
  • The bigger picture: how public and private funding are converging into a global biotech ecosystem.

We'll also share behind-the-scenes context and a look ahead at September — from the next wave of AI-biotech partnerships to new government R&D packages that could reshape where startups take root.

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


🔗 References:

Copyright Music by: Scientific "How it Goes"

]]> Tue, 09 Sep 2025 04:00:00 -0500 Araceli Biosciences Araceli Biosciences 421 In this month’s Funding Focus, host Carli Reyes unpacks the deals, policies, and investments shaping the future of biotech and drug discovery. From billion-dollar pharma bets to government-backed strategies, we explore how capital is accelerating science on a global scale.

What you'll hear:

  • Novo Nordisk’s $550M partnership with Replicate Bioscience to advance self-replicating RNA therapies.
  • The UK’s £1.12B industrial strategy to position Britain as Europe’s biotech hub by 2030.
  • Phenomic AI’s $20M Series A, fueling the convergence of imaging and AI in oncology drug discovery.
  • The bigger picture: how public and private funding are converging into a global biotech ecosystem.

We'll also share behind-the-scenes context and a look ahead at September — from the next wave of AI-biotech partnerships to new government R&D packages that could reshape where startups take root.

Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


🔗 References:

Copyright Music by: Scientific "How it Goes"

]]> Science in Real Time podcast, BioScope podcast, Araceli Biosciences, organoids research, kidney organoids, mini-brains neuroscience, microglia brain development, CellForge AI, predictive biology, stem cell research, drug discovery innovation, precision medicine, disease modeling, prenatal health research, biotech innovation, future of medicine, biomedical science, AI in biology, AI in healthcare, healthcare innovation, medical breakthroughs, synthetic biology, regenerative medicine, digital biology, life science research, biotech community, translational research, medical research advancements No BioScopes: Predictive Biology: Organoids, AI, and the Next Era of Research 1 1 3 3 BioScopes: Predictive Biology: Organoids, AI, and the Next Era of Research full 17fe4a2b-4bbc-4e2b-880a-462d913d398a https://share.transistor.fm/s/7749afe6 In this BioScope episode, host Carli Reyes takes you inside four groundbreaking stories that show how discovery science is evolving from proof-of-concept experiments to predictive, life-like models of human biology. From organoids that grow at the pace of a developing fetus to AI systems that simulate entire cells, this episode reveals how scientists are pushing past traditional limits and creating tools that make biology more realistic, scalable, and powerful.

What You’ll Hear:

  • Kidney organoids on a human timeline — the first fetal kidney models that grow step by step over nine months, opening new windows into birth defects, prenatal gene programs, and drug safety during pregnancy.
  • “Minibrains” with a twist — immune cells called microglia aren’t just cleaning up, but actively building neural circuits, reshaping how we think about brain development and disorders.
  • CellForge AI — a multi-agent AI that builds predictive “virtual cells” you can experiment on in silico, accelerating discovery while reducing reliance on costly lab experiments.
  • Vascularized organoids — mini-hearts and mini-livers sprouting branching blood vessels, finally overcoming a major barrier in organoid research and bringing drug testing and personalized medicine closer to reality.

Together, these stories highlight the convergence of stem cell science, high-content imaging, and AI — a new era where we don’t just observe biology, but predict and design it.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:

Kidney Organoids

Minibrains & Microglia

CellForge AI

Heart Organoids with Vessels

Copyright Music by: Scientific "How it Goes"

]]> In this BioScope episode, host Carli Reyes takes you inside four groundbreaking stories that show how discovery science is evolving from proof-of-concept experiments to predictive, life-like models of human biology. From organoids that grow at the pace of a developing fetus to AI systems that simulate entire cells, this episode reveals how scientists are pushing past traditional limits and creating tools that make biology more realistic, scalable, and powerful.

What You’ll Hear:

  • Kidney organoids on a human timeline — the first fetal kidney models that grow step by step over nine months, opening new windows into birth defects, prenatal gene programs, and drug safety during pregnancy.
  • “Minibrains” with a twist — immune cells called microglia aren’t just cleaning up, but actively building neural circuits, reshaping how we think about brain development and disorders.
  • CellForge AI — a multi-agent AI that builds predictive “virtual cells” you can experiment on in silico, accelerating discovery while reducing reliance on costly lab experiments.
  • Vascularized organoids — mini-hearts and mini-livers sprouting branching blood vessels, finally overcoming a major barrier in organoid research and bringing drug testing and personalized medicine closer to reality.

Together, these stories highlight the convergence of stem cell science, high-content imaging, and AI — a new era where we don’t just observe biology, but predict and design it.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:

Kidney Organoids

Minibrains & Microglia

CellForge AI

Heart Organoids with Vessels

Copyright Music by: Scientific "How it Goes"

]]> Thu, 28 Aug 2025 04:00:00 -0500 Araceli Biosciences Araceli Biosciences 703 In this BioScope episode, host Carli Reyes takes you inside four groundbreaking stories that show how discovery science is evolving from proof-of-concept experiments to predictive, life-like models of human biology. From organoids that grow at the pace of a developing fetus to AI systems that simulate entire cells, this episode reveals how scientists are pushing past traditional limits and creating tools that make biology more realistic, scalable, and powerful.

What You’ll Hear:

  • Kidney organoids on a human timeline — the first fetal kidney models that grow step by step over nine months, opening new windows into birth defects, prenatal gene programs, and drug safety during pregnancy.
  • “Minibrains” with a twist — immune cells called microglia aren’t just cleaning up, but actively building neural circuits, reshaping how we think about brain development and disorders.
  • CellForge AI — a multi-agent AI that builds predictive “virtual cells” you can experiment on in silico, accelerating discovery while reducing reliance on costly lab experiments.
  • Vascularized organoids — mini-hearts and mini-livers sprouting branching blood vessels, finally overcoming a major barrier in organoid research and bringing drug testing and personalized medicine closer to reality.

Together, these stories highlight the convergence of stem cell science, high-content imaging, and AI — a new era where we don’t just observe biology, but predict and design it.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you! 

Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences. 


If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect


References:

Kidney Organoids

Minibrains & Microglia

CellForge AI

Heart Organoids with Vessels

Copyright Music by: Scientific "How it Goes"

]]> Science in Real Time podcast, BioScope podcast, Araceli Biosciences, organoids research, kidney organoids, mini-brains neuroscience, microglia brain development, CellForge AI, predictive biology, stem cell research, drug discovery innovation, precision medicine, disease modeling, prenatal health research, biotech innovation, future of medicine, biomedical science, AI in biology, AI in healthcare, healthcare innovation, medical breakthroughs, synthetic biology, regenerative medicine, digital biology, life science research, biotech community, translational research, medical research advancements No Spotlight: Unlocking the Power of GDPx3 with Naina Kurup, PhD (Ginkgo Datapoints) 1 1 2 2 Spotlight: Unlocking the Power of GDPx3 with Naina Kurup, PhD (Ginkgo Datapoints) full fe7171f5-8e65-400f-ad8c-ca4d9299bb21 https://share.transistor.fm/s/2fd2b399 In this episode of ScienceIRT, host Carli Reyes sits down with Dr. Naina Kurup from Ginkgo Datapoints, a business unit of Ginkgo Bioworks, to discuss the release of the GDPx3 dataset. They dive into what GDPx3 is, how it was built, the scientific and operational challenges behind it, and what it means for the future of biotech and AI-driven discovery.

What You’ll Hear:

  1. Inside Ginkgo Datapoints – making biology easier to engineer through large-scale, AI-ready datasets
  2. The GDPx3 Dataset and breaking down the data – from transcriptomics to high-content imaging, what’s included and how researchers can use it.
  3. Behind the scenes of generating GDPx3, and how Ginkgo’s infrastructure and automation enabled scale and speed.
  4. Cell painting and what academia, pharma, biotech, and startups all stand to gain from open access to GDPx3
  5. Looking Ahead and where to access GDPx3 

Explore the dataset today on the Ginkgo Datapoints website or directly on Hugging Face. For partnership inquiries or dataset support, reach out via the Ginkgo DataPoints contact page or connect with the team on LinkedIn.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect

Copyright Music by: Scientific "How it Goes"

]]> In this episode of ScienceIRT, host Carli Reyes sits down with Dr. Naina Kurup from Ginkgo Datapoints, a business unit of Ginkgo Bioworks, to discuss the release of the GDPx3 dataset. They dive into what GDPx3 is, how it was built, the scientific and operational challenges behind it, and what it means for the future of biotech and AI-driven discovery.

What You’ll Hear:

  1. Inside Ginkgo Datapoints – making biology easier to engineer through large-scale, AI-ready datasets
  2. The GDPx3 Dataset and breaking down the data – from transcriptomics to high-content imaging, what’s included and how researchers can use it.
  3. Behind the scenes of generating GDPx3, and how Ginkgo’s infrastructure and automation enabled scale and speed.
  4. Cell painting and what academia, pharma, biotech, and startups all stand to gain from open access to GDPx3
  5. Looking Ahead and where to access GDPx3 

Explore the dataset today on the Ginkgo Datapoints website or directly on Hugging Face. For partnership inquiries or dataset support, reach out via the Ginkgo DataPoints contact page or connect with the team on LinkedIn.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect

Copyright Music by: Scientific "How it Goes"

]]> Thu, 21 Aug 2025 04:00:00 -0500 Araceli Biosciences Araceli Biosciences 1317 In this episode of ScienceIRT, host Carli Reyes sits down with Dr. Naina Kurup from Ginkgo Datapoints, a business unit of Ginkgo Bioworks, to discuss the release of the GDPx3 dataset. They dive into what GDPx3 is, how it was built, the scientific and operational challenges behind it, and what it means for the future of biotech and AI-driven discovery.

What You’ll Hear:

  1. Inside Ginkgo Datapoints – making biology easier to engineer through large-scale, AI-ready datasets
  2. The GDPx3 Dataset and breaking down the data – from transcriptomics to high-content imaging, what’s included and how researchers can use it.
  3. Behind the scenes of generating GDPx3, and how Ginkgo’s infrastructure and automation enabled scale and speed.
  4. Cell painting and what academia, pharma, biotech, and startups all stand to gain from open access to GDPx3
  5. Looking Ahead and where to access GDPx3 

Explore the dataset today on the Ginkgo Datapoints website or directly on Hugging Face. For partnership inquiries or dataset support, reach out via the Ginkgo DataPoints contact page or connect with the team on LinkedIn.


Got an idea for a topic or a guest you’d love to hear on Science in Real Time? We’d love to hear from you!
Connect with us at our ScienceIRT Website or on LinkedIn: Araceli Biosciences.

If you enjoyed this episode, don’t forget to subscribe, leave us a review, and share it with a colleague who’s just as passionate about shaping the future of biotech as you are!

🔗 Explore & Connect

Copyright Music by: Scientific "How it Goes"

]]> ScienceInRealTime, ScienceIRT, Biotech, Drug Discovery, Araceli Biosciences, SciComms, Science Podcast, STEM Podcast, Podcast Recommendation, Podcast, Now Listening, Life Sciences, NextGen Science, Aracelibio, Science Stories, Behind The Science, Ginkgo Bioworks, Ginkgo Datapoints, Cell Painting, Cell Biology No Opening the Lab Notebook 1 1 1 1 Opening the Lab Notebook trailer fe60aee0-543f-4540-befb-ae69c26e77f6 https://share.transistor.fm/s/67902e2b Welcome to Science in Real Time, a podcast by Araceli Biosciences. In this kickoff episode, host Carli Reyes introduces the mission behind the show — to capture discovery as it happens, not just when it’s published. You’ll learn what to expect each week, why this podcast exists, and how it aims to spotlight the people, tools, and questions that are shaping the future of biotech in real time.

What You’ll Hear:

  1. Why Science in Real Time exists — and why now
  2. Carli’s journey from the bench to the mic
  3. A preview of the show format:
    • BioScope – fast takes on biotech breakthroughs
    • Funding Focus – the business behind the science
    • Molecule Talk – deep dives into biology that matters
    • In the Spotlight – conversations with innovators driving science forward
  4. An invitation to join the community and shape future episodes

Who This Podcast Is For:

  • Bench scientists & postdocs
  • Biotech founders & platform builders
  • Data scientists, investors & curious thinkers
  • Anyone passionate about how scientific discovery happens in the real world

Connect with Us: Got an idea or a guest to nominate? We’d love to hear from you.
Visit: aracelibio.com
LinkedIn: Araceli Biosciences

If you liked this episode: Subscribe, leave a review, and share it with a friend or colleague who’s building the future of biotech! 

Copyright Music by: Scientific "How it Goes"

]]> Welcome to Science in Real Time, a podcast by Araceli Biosciences. In this kickoff episode, host Carli Reyes introduces the mission behind the show — to capture discovery as it happens, not just when it’s published. You’ll learn what to expect each week, why this podcast exists, and how it aims to spotlight the people, tools, and questions that are shaping the future of biotech in real time.

What You’ll Hear:

  1. Why Science in Real Time exists — and why now
  2. Carli’s journey from the bench to the mic
  3. A preview of the show format:
    • BioScope – fast takes on biotech breakthroughs
    • Funding Focus – the business behind the science
    • Molecule Talk – deep dives into biology that matters
    • In the Spotlight – conversations with innovators driving science forward
  4. An invitation to join the community and shape future episodes

Who This Podcast Is For:

  • Bench scientists & postdocs
  • Biotech founders & platform builders
  • Data scientists, investors & curious thinkers
  • Anyone passionate about how scientific discovery happens in the real world

Connect with Us: Got an idea or a guest to nominate? We’d love to hear from you.
Visit: aracelibio.com
LinkedIn: Araceli Biosciences

If you liked this episode: Subscribe, leave a review, and share it with a friend or colleague who’s building the future of biotech! 

Copyright Music by: Scientific "How it Goes"

]]> Fri, 08 Aug 2025 12:01:14 -0500 Araceli Biosciences Araceli Biosciences 429 Welcome to Science in Real Time, a podcast by Araceli Biosciences. In this kickoff episode, host Carli Reyes introduces the mission behind the show — to capture discovery as it happens, not just when it’s published. You’ll learn what to expect each week, why this podcast exists, and how it aims to spotlight the people, tools, and questions that are shaping the future of biotech in real time.

What You’ll Hear:

  1. Why Science in Real Time exists — and why now
  2. Carli’s journey from the bench to the mic
  3. A preview of the show format:
    • BioScope – fast takes on biotech breakthroughs
    • Funding Focus – the business behind the science
    • Molecule Talk – deep dives into biology that matters
    • In the Spotlight – conversations with innovators driving science forward
  4. An invitation to join the community and shape future episodes

Who This Podcast Is For:

  • Bench scientists & postdocs
  • Biotech founders & platform builders
  • Data scientists, investors & curious thinkers
  • Anyone passionate about how scientific discovery happens in the real world

Connect with Us: Got an idea or a guest to nominate? We’d love to hear from you.
Visit: aracelibio.com
LinkedIn: Araceli Biosciences

If you liked this episode: Subscribe, leave a review, and share it with a friend or colleague who’s building the future of biotech! 

Copyright Music by: Scientific "How it Goes"

]]> ScienceInRealTime, ScienceIRT, Biotech, Drug Discovery, Araceli Biosciences, SciComms, Science Podcast, STEM Podcast, Podcast Recommendation, New Podcast, Now Listening, Life Sciences, NextGen Science, Aracelibio, Science Stories, Behind The Science No